Effects of Daily Treatment With Citicoline: A Double-Blind, Placebo-Controlled Study in Cocaine-Dependent Volunteers

被引:14
作者
Licata, Stephanie C. [1 ]
Penetar, David M. [1 ]
Ravichandran, Caitlin [1 ]
Rodolico, John [1 ]
Palmer, Christopher [1 ]
Berko, Jeff [1 ]
Geaghan, Thomas [1 ]
Looby, Alison [1 ]
Peters, Erica [1 ]
Ryan, Elizabeth [1 ]
Renshaw, Perry F. [2 ,3 ]
Lukas, Scott E. [1 ]
机构
[1] Harvard Univ, McLean Hosp, Sch Med, Behav Psychopharmacol Res Lab, Belmont, MA 02478 USA
[2] Univ Utah, Sch Med, Inst Brain, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA
关键词
citicoline; cocaine; alcohol; marihuana; pharmacotherapy; CDP-CHOLINE; ALCOHOL-USE; PATTERNS; ISCHEMIA; RELAPSE; ROUTE;
D O I
10.1097/ADM.0b013e3181d80c93
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Many pharmacotherapies for treating cocaine dependence are aimed at reducing drug effects, alleviating craving, and preventing relapse. We demonstrated previously that citicoline, a compound used to repair neuronal damage in stroke and brain injury, is safe in cocaine-abusing volunteers. Objectives: This study assessed the effectiveness of an 8-week citicoline treatment period and 4-week follow-up in cocaine-dependent individuals. Methods: Twenty-nine healthy nontreatment-seeking, cocaine-dependent male and female volunteers were randomized in this double-blind, placebo-controlled study, 18 of whom completed the treatment period of the study. Participants took citicoline (500 mg twice daily) or matched placebo each day and recorded the measures of craving and drug use. Participants visited the laboratory twice a week for urine screens and to attend weekly group therapy sessions. Results: Citicoline had no effect on cocaine craving or total use. Conclusions: Although the current preliminary results from this small trial suggest that citicoline is not an effective treatment for heavy cocaine users, further investigation on efficacy citicoline as a treatment for substance dependence in other settings may be warranted.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 50 条
  • [31] Ziprasidone Treatment of Refractory Generalized Anxiety Disorder A Placebo-Controlled, Double-Blind Study
    Lohoff, Falk W.
    Etemad, Bijan
    Mandos, Laura A.
    Gallop, Robert
    Rickels, Karl
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 185 - 189
  • [32] Lack of effects of simvastatin on smoking cessation in humans: A double-blind, randomized, placebo-controlled clinical study
    Ingrand, Isabelle
    Solinas, Marcello
    Ingrand, Pierre
    Dugast, Emilie
    Saulnier, Pierre-Jean
    Perault-Pochat, Marie-Christine
    Lafay-Chebassier, Claire
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [33] The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study
    Ray, Lara A.
    Bujarski, Spencer
    Courtney, Kelly E.
    Moallem, Nathasha R.
    Lunny, Katy
    Roche, Daniel
    Leventhal, Adam M.
    Shoptaw, Steve
    Heinzerling, Keith
    London, Edythe D.
    Miotto, Karen
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 (10) : 2347 - 2356
  • [34] Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials
    Secades, Julio J.
    Alvarez-Sabin, Jose
    Castillo, Jose
    Diez-Tejedor, Exuperio
    Martinez-Vila, Eduardo
    Rios, Jose
    Oudovenko, Natalia
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (08) : 1984 - 1996
  • [35] A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients
    Smelson, DA
    Williams, J
    Ziedonis, D
    Sussner, BD
    Losonczy, MF
    Engelhart, C
    Kaune, M
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2004, 27 (01) : 45 - 49
  • [36] A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence
    Farren, Conor K.
    Scimeca, Michael
    Wu, Ran
    Malley, Stephanie O.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2009, 99 (1-3) : 317 - 321
  • [37] A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD
    Kratochvil, Christopher J.
    Vaughan, Brigette S.
    Stoner, Julie A.
    Daughton, Joan M.
    Lubberstedt, Brian D.
    Murray, Desiree W.
    Chrisman, Allan K.
    Faircloth, Melissa A.
    Itchon-Ramos, Nilda B.
    Kollins, Scott H.
    Maayan, Lawrence A.
    Greenhill, Laurence L.
    Kotler, Lisa A.
    Fried, Jane
    March, John S.
    [J]. PEDIATRICS, 2011, 127 (04) : E862 - E868
  • [38] A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram
    Roache, John D.
    Kahn, Roberta
    Newton, Thomas F.
    Wallace, Christopher L.
    Murff, William L.
    De La Garza, Richard, II
    Rivera, Oscar
    Anderson, Ann
    Mojsiak, Jurij
    Elkashef, Ahmed
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2011, 119 (1-2) : 37 - 45
  • [39] Zonisamide in the treatment of painful diabetic neuropathy: A randomized, double-blind, placebo-controlled pilot study
    Atli, A
    Dogra, S
    [J]. PAIN MEDICINE, 2005, 6 (03) : 225 - 234
  • [40] Fluoxetine treatment for prevention of relapse of depression in children and adolescents: A double-blind, placebo-controlled study
    Emslie, GJ
    Heiligenstein, JH
    Hoog, SL
    Wagner, KD
    Findling, RL
    McCracken, JT
    Nilsson, ME
    Jacobson, JG
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (11) : 1397 - 1405